Jennifer Warneke

Jennifer Warneke serves as Executive Vice President and Head of Global Project Leadership at Parexel. With proven success in leading cross-functional teams in project and portfolio execution, she drives operational excellence across Parexel's diverse customer base. In this role, Jennifer partners strategically across the organization to develop and implement operational best practices, processes and innovative solutions that enhance project delivery and customer outcomes. Acting as a key voice for both Parexel and its biopharmaceutical customers, Jennifer is committed to operational process improvement, staff development and delivering exceptional results across therapeutic areas and development phases.

With over 26 years of pharmaceutical development and CRO experience in the academic and industry space, Jennifer brings deep expertise in clinical operations, oncology, and strategic leadership to her role at Parexel. Her comprehensive expertise spans global project management, financial performance optimization, early phase through late-stage clinical development, pediatric trial conduct, clinical operations management, and clinical trial technology implementation. 

Prior to joining Parexel, Jennifer served as Senior Vice President of Clinical Operations for G1 Therapeutics, Inc., an oncology-focused biopharmaceutical company, where she oversaw clinical operations, data management and clinical trial supplies. Her experience also includes various leadership roles at Syneos Health, including Senior Vice President of Global Oncology Operations, where she led operational and financial delivery for the oncology business unit, as well as Vice President roles in Oncology Clinical Operations, Clinical Development and Global Operations Management.

Jennifer was recognized as a Rising Star member of the Healthcare Businesswomen's Association (HBA) Class of 2021. She holds a Bachelor of Arts in Communications from Brigham Young University.